Peering Into Edwards Lifesciences's Recent Short Interest
Portfolio Pulse from Benzinga Insights
Edwards Lifesciences (NYSE:EW) has seen a 6.28% decrease in short interest since its last report, with 10.75 million shares sold short, representing 1.79% of its float. The average time to cover these short positions is 2.28 days. Short interest is a measure of market sentiment, and a decrease may indicate a more bullish outlook. However, this does not necessarily predict a near-term price rise. Compared to its peers, EW has a lower short interest as a percentage of float, with the peer group average at 3.72%.
November 28, 2023 | 6:45 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Edwards Lifesciences's short interest has decreased, which may suggest a more bullish sentiment among investors. However, this is not a definitive indicator of a near-term price increase.
A decrease in short interest typically indicates that investors are less bearish on the stock, which could lead to a potential increase in its price in the short term. However, the impact is not guaranteed as short interest is just one of many factors that influence stock prices.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 100